Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
81.97B | 94.82B | 91.17B | 90.80B | 80.03B | Gross Profit |
30.46B | 35.15B | 34.19B | 35.28B | 30.21B | EBIT |
4.24B | 30.62B | 11.83B | 12.10B | -3.10B | EBITDA |
14.62B | 35.57B | 16.07B | 16.41B | 8.55B | Net Income Common Stockholders |
4.32B | 28.85B | 6.27B | 5.12B | -10.10B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
21.03B | 14.08B | 11.61B | 22.89B | 29.26B | Total Assets |
476.56B | 447.75B | 434.77B | 436.32B | 433.11B | Total Debt |
99.47B | 74.90B | 73.29B | 66.89B | 73.32B | Net Debt |
79.65B | 63.06B | 61.67B | 43.99B | 44.05B | Total Liabilities |
157.89B | 122.98B | 118.83B | 112.15B | 113.96B | Stockholders Equity |
258.30B | 268.13B | 258.46B | 266.95B | 262.69B |
Cash Flow | Free Cash Flow | |||
6.05B | 6.32B | 4.73B | 7.45B | 8.46B | Operating Cash Flow |
10.46B | 9.92B | 8.16B | 11.66B | 11.46B | Investing Cash Flow |
-14.60B | 13.03B | -17.54B | -6.34B | 1.73B | Financing Cash Flow |
12.62B | -21.73B | -1.40B | -12.34B | -5.69B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
$10.63B | 21.51 | 1.64% | 5.09% | ― | ― | ||
66 Neutral | $4.50B | 12.29 | 5.40% | 248.66% | 4.13% | -12.33% | |
$5.33B | 7.04 | 4.88% | ― | ― | |||
$22.40B | 10.16 | 3.16% | 4.86% | ― | ― | ||
$4.63B | 43.65 | -3.59% | 0.97% | ― | ― | ||
$2.69B | 5.37 | 6.40% | 6.00% | ― | ― | ||
75 Outperform | HK$83.41B | 3.54 | 1.64% | 6.19% | -13.56% | -84.68% |